Indication
Transplant Rejection
2 clinical trials
8 products
1 drug
Product
CorticosteroidsProduct
BIVV020Product
Intravenous immunoglobulinClinical trial
A Multi-cohort, Randomized, Phase 2, Open-label Study to Assess the Preliminary Efficacy, Safety, and Pharmacokinetics of BIVV020 for Prevention and Treatment of Antibody-mediated Rejection in Adult Kidney Transplant Recipients.Status: Recruiting, Estimated PCD: 2024-11-14
Product
TacrolimusProduct
MycophenolateProduct
RituximabProduct
Antithymocyte globulinClinical trial
Once-Daily Extended-Release Tacrolimus vs. Twice-Daily Tacrolimus: Impact on T-Cell Subpopulations and Markers of Renal Tubule-toxicity in Kidney Transplant PatientsStatus: Completed, Estimated PCD: 2021-02-23
Drug
Varlilumab